Cote d'Ivoire: Côte d’Ivoire Becomes Second African Country and First French-Speaking Country to Receive Vaccine Doses via COVAX Facility

press release

Abidjan — The COVAX initiative shipped 504,000 doses of the AstraZeneca/Oxford vaccine, licensed by the Serum Institute of India, to India, and 505,000 syringes to Abidjan, on 26 February 2021. This marks the second batch that has been shipped and delivered to Africa by the COVAX Facility in an unprecedented effort to provide at least 2 billion doses of COVID-19 vaccine by the end of 2021.

The vaccine doses were received at Abidjan International Airport by Côte d'Ivoire’s Minister of Health and Public Hygiene, Dr Eugène Aka Aouélé, accompanied by members of the COVAX Facility – the Vaccine Alliance (Gavi), the Coalition for Epidemic Preparedness Innovations (CEPI), the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO) – in addition to the United Nations Development System (UNDS) Resident Coordinator in Côte d'Ivoire and the ambassadors of the European Union countries, whose funding enabled manufacturing, transport and distribution of the vaccine. The vaccines transported by UNICEF came from India (Mumbai), and were transported through Dubai where a shipment of syringes from a Gavi-funded stockpile was collected from UNICEF's regional supply centre. UNICEF strives to monitor vaccines throughout the supply chain, from the factory gate to the port of entry in each country.

...

AllAfrica publishes around 500 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.